Use of current and new endpoints in the evaluation of experimental hepatitis B therapeutics
Author(s):
Timothy M. Block, Stephen Locarnini, Brian J. McMahon, Barbara Rehermann, Marion G. Peters
Details:
Clinical Infectious Diseases, Volume 64, Issue 9, 2017-05-01
Article Link: Click here
Affiliations:
- National Institutes of Health (NIH)
- UCSF School of Medicine
- The Peter Doherty Institute for Infection and Immunity
- Baruch S. Blumberg Institute
- Alaska Native Medical Centre

